Innovating Works

BIAL INDUSTRIAL FARMACÉUTICA, S.A.

Activa
IBDIMAGE: Disruptive fluorescent technologies for inflammatory bowel diseases BIAL INDUSTRIAL FARMACÉUTICA, S.A. participó en un H2020: ERC-2020-PoC Inflammatory bowel diseases (IBD) are chronic immune-mediated disorders causing inflammation of the gastrointestinal tract, which affect aro...
2020-07-31 - 2022-10-31 | Financiado
NUVOIC: Accessible Voice Activated Technologies in a Voice First World BIAL INDUSTRIAL FARMACÉUTICA, S.A. participó en un H2020: H2020-EIC-FTI-2018-2020 The objective of this FTI project is to bring two unique and complementary commercial products to the market: Nuvoic Home and Nuvoic Shop. A...
2020-04-29 - 2023-04-30 | Financiado
OSTOFORM: Novel Device for Improving Ostomy Skin Condition BIAL INDUSTRIAL FARMACÉUTICA, S.A. participó en un H2020: H2020-EIC-SMEInst-2018-2020 Ostoform is a spin-out medical device company from the University of Limerick, Ireland with a range of patented technologies, and the potent...
2019-05-09 - 2021-10-31 | Financiado
BEBOP: Bacterial biofilms in porous structures from biomechanics to control BIAL INDUSTRIAL FARMACÉUTICA, S.A. participó en un H2020: ERC-2018-STG The key ideas motivating this project are that: 1) precise control of the properties of porous systems can be obtained by exploiting bacteri...
2018-11-30 - 2024-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.